Médecins Sans Frontières response to release of WHO’s Global Tuberculosis Report 2018

Dear All,

WHO will be releasing its Global TB report 2018 at New York today. Please find our response to the report which is embargoed till 18:00 CEST today.





Médecins Sans Frontières (MSF)/Doctors Without Borders response to release of WHO’s Global Tuberculosis Report 2018


New York, 18 September, 2018—The World Health Organization (WHO) released its annual Global TB Report today, one week before heads of state will convene at the UN’s first-ever summit on tuberculosis (TB), the UN High-level Meeting on TB on September 26th.

The report highlights sluggish global progress on TB, indicating that countries will not be able to meet their targets in the  ‘End TB’ strategy at this slow pace. TB remains the world’s leading infectious disease killer, taking 1.6 million lives in 2017 (compared to 1.7 million in 2016), with 10 million people developing TB in 2017 (about 10.4 million people had TB in 2016). Of grave concern are the prevailing gaps in diagnosing and treating people with TB: in 2017, 64% people with TB were diagnosed and their cases reported (compared to 61% in 2016). Among people with drug-resistant TB (DR-TB), 25% of people who were diagnosed were also treated (compared to 22% in 2016).

The WHO will also release new treatment guidelines for DR-TB this year, which will recommend using the newer drug bedaquiline as part of the core treatment regimen.

Sharonann Lynch, HIV & TB Policy Advisor, MSF Access Campaign:

“The latest TB epidemic figures are a shameful report card on the world’s failure to confront this curable disease that continues to kill more than a million and a half people each year. Governments continue to tackle the world’s deadliest infectious disease with lethal mediocrity.  Seven years in a row now, about 40% of people with TB persistently remain undiagnosed, when we have the means to do so much better. If we’re not even diagnosing people with TB, how are they supposed to get treated?

The world’s leaders must seize the opportunity of the first-ever TB summit to curb and reverse TB’s deplorable trajectory. The TB summit must be a reckoning of these global failures and must not simply restate earlier promises to end TB by 2030. Such promises mean nothing if the governments do not commit to test and treat more people tomorrow and provide significant funding to bring out affordable new treatments, diagnostics and vaccines. Millions of people with TB around the world are waiting for the political commitment to turn this epidemic around and stop the senseless deaths and suffering caused by the disease. It’s time to smash the TB status quo—what are we waiting for?”



Shailly Gupta

Press & Communications Officer

MSF Access Campaign

Médecins Sans Frontières

Ph: +41 22 849 9334

M: +41 79 203 13 02

Skype: Shailly.17 |Twitter: @shaillytweeting



About Médecins Sans Frontières (MSF) Access Campaign

In 1999, in the wake of Médecins Sans Frontières (MSF) being awarded the Nobel Peace Prize, MSF launched the Access Campaign. Its purpose has been to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond.

Médecins Sans Frontières (MSF) Access Campaign
Rue de Lausanne 78
P.O Box 1016
CH-1211 Geneva 1